Quick Answer
Maze Therapeutics, Inc. reported Total Assets of $397.13 million for fiscal year 2025.
Maze Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $397.13M | +65.1% |
| 2024 | $240.54M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $422.06M | — | +39.1% |
| June 30, 2025 | $303.52M | — | -8.8% |
| March 31, 2025 | $332.84M | — | +38.4% |
| December 31, 2024 | $240.54M | — | — |
- Maze Therapeutics, Inc. showed an increase of +65.1% in Total Assets compared to the prior fiscal year.
- Over the 2024–2025 period, Maze Therapeutics, Inc.’s total assets has grown by 65.1% (from $240.54 million to $397.13 million).
- The most recent figure is from Maze Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: